No products in the cart.

Anti-Nuclear Matrix Protein p84 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-3217
Anti-Nuclear Matrix Protein p84 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-3217
Product type: Primary antibody
Antigen: Nuclear Matrix Protein p84
Immunogen: Recombinant protein
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:600-1:2000); Immunohistochemistry (1:60-1:200); Immunocytochemistry (1:60-1:200)
Reactivity: Mouse, Rat and Human
Clonality (clone number): Monoclonal (JU53-18)
Form: Liquid
Buffer: Tris-HCl buffer (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: hTREX84 antibody
Death domain containing protein p84N5 antibody
HPR 1 antibody
HPR1 antibody
hTREX84 antibody
Nuclear matrix protein p84 antibody
P84 antibody
p84N5 antibody
Tho 1 antibody
THO complex 1 antibody
THO complex subunit 1 antibody
Tho1 antibody
THOC 1 antibody
Thoc1 antibody
THOC1_HUMAN antibody
Show More

Target information

Required for efficient export of polyadenylated RNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5′ end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi’s sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. Regulates transcriptional elongation of a subset of genes. Involved in genome stability by preventing co-transcriptional R-loop formation.
Participates in an apoptotic pathway which is characterized by activation of caspase-6, increases in the expression of BAK1 and BCL2L1 and activation of NF-kappa-B. This pathway does not require p53/TP53, nor does the presence of p53/TP53 affect the efficiency of cell killing. Activates a G2/M cell cycle checkpoint prior to the onset of apoptosis. Apoptosis is inhibited by association with RB1.

Provider

Erpantech Laboratory

download

MSDS-AB-06-3217.pdf (55 downloads)